Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... devices (IUDs), -           intra-uterine hormone -releasing systems (IUSs), -           bilateral tubal ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  2. Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway

    ... the Wnt pathway using lithium chloride or parathyroid hormone . Its hematopoiesis -supporting capacity was reduced, while ...

    Research Article last updated 11/08/2017 - 8:52am.

  3. Eltrombopag Added to IST Yields Encouraging Results

    “Our current work demonstrates that stimulating remaining stem cells with a drug that mimics the actions of a natural growth substance for marrow stem cells while suppressing the immune system improves th...

    Interview last updated 05/24/2017 - 7:44am.

  4. The National Myelodysplastic Syndromes Natural History Study

    ... folate , ferritin , and Thyroid-Stimulating Hormone (TSH) tests performed in prior 6 months ...

    Clinical Trial last updated 02/23/2017 - 1:36pm.

  5. Aplastic anemia

    ... hematopoietic stem cell transplantation, and anabolic hormone therapy. Although transplantation provides complete recovery of ...

    Research Article last updated 11/01/2016 - 1:58pm.

  6. Growth Factors

    ... called erythropoietin or EPO for short. It is a hormone naturally produced in the kidneys. Your kidneys make more EPO in ... growth factor is called thrombopoietin. It is a hormone produced by the liver and kidney which stimulates the production of ...

    Topic section last updated 04/06/2016 - 12:37pm.

  7. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... Researchers are studying the use of drugs that lower hormone levels and may allow the immune system to recover in a way that ... receive regular lupron doses 2 weeks before BMT to suppress hormone function. All recipients will receive 4 days of radiation followed ...

    Clinical Trial last updated 04/28/2016 - 11:14am.

  8. Iron Overload and MDS

    ... with MDS decreases the liver’s production of a hormone called hepcidin. This then leads to an increase in absorption of ...

    Research Review last updated 05/02/2016 - 9:18am.

  9. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... status of the woman has been confirmed by follow up hormone level assessment is she considered not of child bearing potential. ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  10. GVAX vs. Placebo for MDS/AML After Allo HSCT

    ... specific to that cancer. GM-CSF is a naturally occurring hormone in the body that helps the immune system fight infections and ...

    Clinical Trial last updated 04/28/2016 - 12:01pm.